A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol

Authors

Adriana C. H. van Engen–van Grunsven (ORCID: https://orcid.org/0000-0002-3154-3601)
Marianne A. Jonker (ORCID: https://orcid.org/0000-0003-0134-8482)
Gerald W.C.T Verhaegh (ORCID: https://orcid.org/0000-0003-0227-2280)
Carla M.L. van Herpen (ORCID: https://orcid.org/0000-0001-5130-5451)
Gerben Lassche (ORCID: https://orcid.org/0000-0002-4935-6206)
Nielka P. van Erp (ORCID: https://orcid.org/0000-0003-1553-178X)
Jetty A.M. Weijers (ORCID: https://orcid.org/0000-0002-1165-7417)
Jack A. Schalken (ORCID: https://orcid.org/0000-0001-8274-7797)
C.M.L. Driessen (ORCID: https://orcid.org/0000-0001-8665-6323)

Institutions

Radboud University Nijmegen (NL)
Radboud University Medical Center (NL)
Radboud Institute for Molecular Life Sciences (NL)

Publication Details

Journal: BMC Cancer
Published: 2024-09-20
DOI: https://doi.org/10.1186/s12885-024-12889-0
Citations: 5
Primary Topic: Salivary Gland Tumors Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 2.86

Funders

ZonMw
Leids Universitair Medisch Centrum
Radboud Universitair Medisch Centrum
Servier
Universitaire Ziekenhuizen Leuven, KU Leuven

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol

Adriana C. H. van Engen–van Grunsven, Marianne A. Jonker, Gerald W.C.T Verhaegh, Carla M.L. van Herpen et al.

Sep 20, 2024

5 citations

BMC Cancer

Salivary Gland Tumors Diagnosis and Treatment

2.86

article

A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol

Adriana C. H. van Engen–van Grunsven, Marianne A. Jonker, Gerald W.C.T Verhaegh, Carla M.L. van Herpen, Gerben Lassche, Nielka P. van Erp, Jetty A.M. Weijers, Jack A. Schalken, C.M.L. Driessen

September 20, 2024article en

5 citations

Abstract

No abstract available for this paper.

BMC CancerVol. 24(1)

Radboud University Nijmegen (NL), Radboud University Medical Center (NL), Radboud Institute for Molecular Life Sciences (NL)

ZonMw, Leids Universitair Medisch Centrum, Radboud Universitair Medisch Centrum, Servier, Universitaire Ziekenhuizen Leuven, KU Leuven

Good health and well-being

Openalex Percentile: Top 9%

Salivary Gland Tumors Diagnosis and Treatment

2.86

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol — Adriana C. H. van Engen–van Grunsven, Marianne A. Jonker, et al. · BMC Cancer (2024) | TGRS Research Map | TGRS